Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / March / Women and Liver Fibrosis Risk New Insights
Genetics and epigenetics Screening and monitoring Research and Innovations

Women and Liver Fibrosis Risk: New Insights

Study reveals sex-specific differences in fibrosis associations

03/17/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Share

Top Institutions in Hepatology and Metabolic Liver Disease

Institutions leading in this area typically conduct large-scale epidemiological studies, utilize advanced noninvasive diagnostic tools like transient elastography, and integrate metabolic and cardiovascular risk profiling to understand liver fibrosis progression, with a focus on sex differences.

  • #1

    Mayo Clinic

    Rochester, MN

    Mayo Clinic is a leader in hepatology research with extensive expertise in noninvasive liver fibrosis assessment and metabolic liver disease, supported by robust clinical trials and translational research programs.

    Key Differentiators

    • Hepatology
    • Metabolic Diseases
    • Cardiology
  • #2

    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    UCSF has a leading hepatology division with a focus on metabolic liver diseases and sex differences in liver fibrosis, supported by extensive population-based research and clinical trials.

    Key Differentiators

    • Hepatology
    • Endocrinology
    • Epidemiology
  • #3

    Johns Hopkins University

    Baltimore, MD

    Johns Hopkins is renowned for its epidemiological research on liver fibrosis and cardiometabolic risk, with a focus on integrating cardiovascular and metabolic factors in liver disease progression.

    Key Differentiators

    • Hepatology
    • Cardiology
    • Epidemiology
  • #4

    Cleveland Clinic

    Cleveland, OH

    Cleveland Clinic has a comprehensive liver disease program with expertise in metabolic liver disease and cardiometabolic risk assessment, emphasizing noninvasive diagnostics and personalized medicine.

    Key Differentiators

    • Hepatology
    • Metabolic Medicine
    • Cardiology

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Genetics and epigenetics
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Molecular Spectacular
Genetics and epigenetics
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Redefining Diagnostic Reference Standards
Genetics and epigenetics
Redefining Diagnostic Reference Standards

January 3, 2022

1 min read

Find out what Horizon Discovery’s diagnostic reference standards can do for your workflow

Defining the Next Generation of NGS
Genetics and epigenetics
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.